Between Europe and China there is another large and growing market. Russia and its 142 million consumers represent an important and still largely untapped opportunity. Russia continually vies with Saudi Arabia for the title of world’s leading oil producer, and with the U.S. for the title of top natural gas producer. The country is considered to hold the world’s greatest reserves of natural gas, and the second greatest coal reserves. It’s a top exporter of steel and aluminum, also exporting copper, iron, nickel, and many other metals and minerals.
With low unemployment and a gross domestic product of over $2.5 trillion, yet with a number of still developing sectors, Russia is drawing in foreign investment, and the Russian government is actively encouraging the growth of non-resource industries, with a special emphasis on technology. An example is the Russian pharmaceutical industry, where the government is anxious to reduce dependence upon foreign supplies for important drugs, and is encouraging the growth of pharmaceutical companies.
Rafarma Pharmaceuticals is a fast-growing pharmaceutical company in Russia that is benefitting from this encouragement. The company recently completed construction of the most technologically advanced pharmaceutical facilities in Russia, and is already producing generic antibiotics and specialty pharmaceuticals, in addition to its own line of proprietary products. Rafarma is already securing its foothold in the industry, and its marketing plans have already led to the company being considered the principle supplier to the Russian Public Health system and the Russian Army.
Rafarma Pharmaceuticals is now fully GDP compliant, and GCP and GMP standards are in their last stages of approval. The company is also working to become GLP and GAP compliant, at which time Rafarma Pharmaceuticals will be one of the only Russia-based pharmaceutical companies representing the complete cycle of the world’s top pharmaceutical standards.
For more information, visit www.rafarma.us
Let us hear your thoughts: Rafarma Pharmaceuticals, Inc. Message Board